SIPORE Trademark

Trademark Overview


On Friday, June 1, 2018, a trademark application was filed for SIPORE with the United States Patent and Trademark Office. The USPTO has given the SIPORE trademark a serial number of 79245402. The federal status of this trademark filing is REGISTERED as of Tuesday, March 3, 2020. This trademark is owned by Sigrid Therapeutics AB. The SIPORE trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Dietetic preparations adapted for medical use; dietetic substances in the nature of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions adapted for medical use; pharmaceuticals and natural remedies for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; preparations for use in naturopathy for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; nutritional supplements; chemical preparations for medical purposes for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; pharmaceutical preparations and chemico- pharmaceutical preparations for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the impro...

Surgical and medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; capsulated medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; medical devices for the treatment and prevention of obesity and being overweight, and for use in weight control; medical devices for the treatment and prevention of prediabetes, diabetes and glycemic control, and for the improvement of overall metabolic health; medical devices for use in the prevention and treatment of prediabetes and diabetes; orally administered medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; surgical and medical devices, capsulated devices and orally administered medical devices all ...
sipore

General Information


Serial Number79245402
Word MarkSIPORE
Filing DateFriday, June 1, 2018
Status700 - REGISTERED
Status DateTuesday, March 3, 2020
Registration Number5999045
Registration DateTuesday, March 3, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 17, 2019

Trademark Statements


Goods and ServicesDietetic preparations adapted for medical use; dietetic substances in the nature of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions adapted for medical use; pharmaceuticals and natural remedies for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; preparations for use in naturopathy for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; nutritional supplements; chemical preparations for medical purposes for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; pharmaceutical preparations and chemico- pharmaceutical preparations for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; dietary and nutritional supplements; health food supplements for persons with special dietary requirements; chemical preparations for pharmaceutical purposes for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; pharmaceutical preparations and substances for glycemic control; pharmaceutical preparations and substances for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; dietetic preparations and substances for glycemic control; dietetic preparations and substances for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; dietary and nutritional supplements for glycemic control; dietary and nutritional supplements for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; pharmaceutical preparations in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in glycemic control; pharmaceutical preparations in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; pharmaceutical preparations and substances, dietary and nutritional substances in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, colitis; pharmaceutical preparations and substances, dietary and nutritional substances in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of intestinal injury or inflammation, Crohn's disease, cardiovascular risk factors, post bariatric surgery patients, and not including products primarily for use in the treatment of angina pectoris and high blood pressure
Goods and ServicesSurgical and medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; capsulated medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; medical devices for the treatment and prevention of obesity and being overweight, and for use in weight control; medical devices for the treatment and prevention of prediabetes, diabetes and glycemic control, and for the improvement of overall metabolic health; medical devices for use in the prevention and treatment of prediabetes and diabetes; orally administered medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; surgical and medical devices, capsulated devices and orally administered medical devices all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, intestinal injury or inflammation, colitis, Crohn's disease, cardiovascular risk factors, post bariatric surgery patients

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 19, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, November 19, 2018
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSigrid Therapeutics AB
Party Type30 - Original Registrant
Legal Entity Type64 - NOT AVAILABLE
AddressSE

Party NameSigrid Therapeutics AB
Party Type20 - Owner at Publication
Legal Entity Type64 - NOT AVAILABLE
AddressSE

Party NameSigrid Therapeutics AB
Party Type10 - Original Applicant
Legal Entity Type64 - NOT AVAILABLE
AddressSE

Trademark Events


Event DateEvent Description
Sunday, April 2, 2023NEW REPRESENTATIVE AT IB RECEIVED
Sunday, January 29, 2023NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 24, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, July 8, 2020FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, July 8, 2020FINAL DISPOSITION PROCESSED
Wednesday, June 3, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 3, 2020REGISTERED-PRINCIPAL REGISTER
Friday, December 20, 2019NOTIFICATION PROCESSED BY IB
Tuesday, December 17, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 17, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 4, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 4, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 14, 2019ASSIGNED TO LIE
Sunday, November 10, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 5, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 4, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 4, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, June 13, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, June 13, 2019FINAL REFUSAL E-MAILED
Thursday, June 13, 2019FINAL REFUSAL WRITTEN
Tuesday, June 4, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 3, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 3, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 8, 2019ATTORNEY REVIEW COMPLETED
Thursday, February 7, 2019LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Friday, February 1, 2019LIMITATION OF GOODS RECEIVED FROM IB
Friday, December 21, 2018REFUSAL PROCESSED BY IB
Tuesday, December 4, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, December 4, 2018REFUSAL PROCESSED BY MPU
Friday, November 23, 2018APPLICATION FILING RECEIPT MAILED
Wednesday, November 21, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, November 20, 2018NON-FINAL ACTION WRITTEN
Monday, November 19, 2018ASSIGNED TO EXAMINER
Monday, November 19, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 15, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB